Why Cardiologists Seek a Temporary Moratorium on Fee Cuts

Cardiologists are calling for a temporary moratorium on fee schedule changes because payment reductions can become an access problem before they appear in clinic budgets. The American College of Cardiology launched Campaign for Patient Access to oppose proposed cuts to the Medicare physician fee schedule in the United States and defend timely cardiovascular care. Its argument is practical: a policy designed to adjust federal spending must not leave patients with fewer appointments, delayed tests or withdrawn services.

For Australian readers, this is a warning from a neighbouring health system rather than a proposal to freeze Medicare Australia. Medicare here operates through the Medicare Benefits Schedule, public hospital services and private coverage, so no US payment rule applies directly. The mechanics still feel familiar when rebates or insurer payments fail to keep pace with the cost of running specialist practices, especially where public waiting lists already push care into the private sector.

What a temporary moratorium would actually do

A moratorium would suspend scheduled reductions for a defined period rather than cancel Medicare spending or freeze every physician payment. It would create time for agencies, clinicians and patients to assess whether lower rates reflect sustainable savings or simply transfer an unfunded cost to cardiovascular services. A well-designed pause would use clear start and end dates, require public reporting on access, and preserve payment levels that had already taken effect.

The campaign focuses on the Medicare physician fee schedule, which determines how much Medicare pays many physicians for outpatient and office services. Cuts to that schedule can spread across consultations, procedures and diagnostic work because practices often support several revenue streams with the same staff, equipment and premises. The impact varies by specialty, setting and participation status, yet cardiologists warn that even moderate reductions can tighten staffing and appointment capacity over several budget cycles.

Responses can move through several legal and legislative channels. Interested groups can submit evidence during federal rulemaking, seek congressional scrutiny or legislation, and ask courts to review whether the agency followed its statutory duties. Courts cannot substitute their own budget judgment for policymakers, so a congressional pause may offer the clearest legal certainty. A temporary freeze would buy time without pretending that the underlying cost problem has disappeared.

Why cardiovascular care cannot absorb prolonged underpayment

Cardiology practices carry unusually fixed costs: echocardiography equipment, trained nurses, ECG services, imaging systems and secure referral networks. A lower payment for one visit may not produce a matching saving. Instead, a practice can respond by shortening consultations, reducing nurse hours, declining marginal referrals or postponing equipment replacement, with consequences that reach beyond the appointment directly affected.

Patients experience these decisions through waiting times. A delayed cardiology review may mean a missed diagnosis, a postponed procedure or additional travel for a test. Families may also lose continuity when a familiar clinician leaves. Personal accounts are therefore valuable evidence: they show how an ostensibly technical rate adjustment changes work, transport, stress and household finances in real communities.

That is why Campaign for Patient Access asks patients, practices and professional bodies to document the consequences rather than treat fee policy as an abstract budget issue. Its patient access guide offers a public-facing starting point for understanding the campaign and the ways communities can respond. The strongest cases pair a patient’s account with verified operational data from the practice, including appointment availability, wait times and staffing changes.

What the policy debate means in Australia

Australia’s Medicare uses the Medicare Benefits Schedule, or MBS, to set rebates for many consultations and tests. Federal ministers and departments review items and may use legal instruments to amend them, while specialist groups often provide evidence about clinical effects. Private health insurance rebates and negotiated schedules then add another layer, so a change in one part of the market does not necessarily produce an equal change in what patients receive.

Public cardiology services are delivered through public hospital outpatient departments and community clinics, including major networks in Sydney and Melbourne. Long waiting lists can make a private review feel like the quickest route, while referred tests in Brisbane or Perth may still be scheduled through a public pathway. Patients commonly navigate a Medicare card, a GP referral and out-of-pocket costs, and they may lack a clear view of which funding stream is causing a delay.

Regional and remote patients face a sharper version of the same problem. Cardiac reviews may require travel to Adelaide, Perth or a metropolitan centre, while telehealth can reduce some travel without replacing emergency imaging, procedures or hands-on care. Thin specialist workforces also mean that withdrawal from a town can affect local general practitioners for years. Australian policymakers therefore need to evaluate access, not merely the headline percentage attached to a rebate.

The US campaign nevertheless offers a useful policy test: would a funding change be implemented only after specialists, hospitals, rural services and patients have had a credible chance to report its effects? Australia need not copy an American institutional model. It can apply that test to MBS reviews, private insurer agreements and public hospital funding, using transitional periods and targeted support where a cut would threaten essential capacity.

A clear comparison of the two systems

The two systems use different payment instruments and decision-makers, but both must balance savings with access. The comparison below highlights the practical lesson without treating Medicare Australia and Medicare in the United States as interchangeable.

Issue	United States campaign	Australian context
Main payment instrument	Medicare physician fee schedule	MBS rebates, public hospital funding and private insurance
Key decision makers	Federal agency, Congress and courts	Federal government, relevant ministers and Parliament
Principal risk	Clinicians absorb cuts through capacity, staffing and access	Rebate pressure affects specialist viability and public waiting lists
Useful safeguard	Time-limited pause with access reporting	Staged MBS changes, transition support and rural safeguards
Evidence needed	Patient accounts, staffing data and service volumes	Referral data, waiting times, travel burdens and out-of-pocket costs

A moratorium works best when it has measurable conditions rather than serving as a blank cheque. It should identify which rates are paused, who benefits, how access will be monitored and what evidence is required before changes resume. Public reporting can reveal whether appointments, service locations and high-risk referrals are protected; without that information, a pause could merely delay the same pressure.

Actions patients and practices can take now

Campaign for Patient Access relies on public participation, professional evidence and communication with decision-makers. Patients can explain what delayed access means in daily life, while clinicians can show how payment policy affects safe service delivery. Australian experience can also inform the broader debate, although evidence about the US Medicare schedule should be identified as such. Campaign news and practice resources help participants distinguish a proposed rule from a final decision before acting.

For patients and families:

• Ask your GP or treating specialist which referral, test and follow-up steps are affected by public or private funding.
• Keep a dated record of waiting times, cancelled appointments, travel and out-of-pocket costs.
• Write a short personal account describing how a delay affected work, family responsibilities or treatment choices.
• Contact a federal MP about Medicare funding and a state MP when the main issue is public hospital access.
• Share verified information with community health organisations and the campaign without exposing another person’s details.

For cardiologists and practices:

• Quantify effects on appointment volume, waiting times, staffing, service locations and high-risk referrals.
• Record examples where inadequate payment led to reduced continuity, delayed equipment or additional patient travel.
• Submit evidence to relevant Australian consultations and to specialty colleges when Medicare or public hospital funding is under review.
• Engage with the American College of Cardiology when your operational experience specifically concerns Medicare in the United States.
• Explain access consequences plainly, avoid shifting all costs to patients and seek transition measures for clinically necessary services.

Add your voice now by sharing a personal story with Campaign for Patient Access, documenting the practical effects of payment changes and sending that evidence to elected representatives. Patients should connect the policy to missed care, travel and financial strain; cardiologists should connect it to staffing, equipment and service availability. Clear, factual accounts can help lawmakers see whether a temporary pause protects access or whether a final cut would push costs and risks back into communities.